The therapeutic role of 5-HT1A and 5-HT2A receptors in depression

被引：1

作者：

Celada, P ^{[1
]}

Puig, MV ^{[1
]}

Amargós-Bosch, M ^{[1
]}

Adell, A ^{[1
]}

Artigas, F ^{[1
]}

机构：

[1] CSIC, Dept Neurochem, Inst Invest Biomed, Barcelona 08036, Spain

来源：

JOURNAL OF PSYCHIATRY & NEUROSCIENCE | 2004年 / 29卷 / 04期

关键词：

antidepressive agents; depression; dorsal raphe nucleus; gamma-aminobutyric acid; medial prefrontal cortex; microdialysis; pindolol; receptors; AMPA; serotonin; serotonin uptake inhibitors;

D O I：

暂无

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

The selective serotonin reuptake inhibitors (SSRIs) are the most frequently prescribed antidepressant drugs, because they are well tolerated and have no severe side effects. They rapidly block serotonin (5-HT) reuptake, yet the onset of their therapeutic action requires weeks of treatment. This delay is the result of presynaptic and postsynaptic adaptive mechanisms secondary to reuptake inhibition. The prevention of a negative feedback mechanism operating at the 5-HT autoreceptor level enhances the neurochemical and clinical effects of SSRIs. The blockade of 5-HT2A receptors also seems to improve the clinical effects of SSRIs. These receptors are located postsynaptically to 5-HT axons, mainly in the neocortex. Pyramidal neurons in the prefrontal cortex are particularly enriched in 5-HT2A receptors. Their blockade may affect the function of prefrontal-subcortical circuits, an effect that probably underlies the beneficial effects of the addition of atypical antipsychotic drugs, which are 5-HT2A receptor antagonists, to SSRIs in treatment-resistant patients.

引用

页码：252 / 265

页数：14

共 50 条

[21] On the Functional Cross-Talk between Brain 5-HT1A and 5-HT2A Receptors
Naumenko, V. S.
Bazovkina, D. V.
Kondaurova, E. M.
ZHURNAL VYSSHEI NERVNOI DEYATELNOSTI IMENI I P PAVLOVA, 2015, 65 (02) : 240 - 247
[22] Molecular dynamics of buspirone analogues interacting with the 5-HT1A and 5-HT2A serotonin receptors
Bronowska, A
Les, A
Chilmonczyk, Z
Filipek, S
Edvardsen, O
Ostensen, R
Sylte, I
BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (04) : 881 - 895
[23] Molecular dynamics of 5-HT1A and 5-HT2A serotonin receptors with methylated buspirone analogues
Agnieszka Bronowska
Zdzisław Chilmonczyk
Andrzej Leś
Øyvind Edvardsen
Roy Østensen
Ingebrigt Sylte
Journal of Computer-Aided Molecular Design, 2001, 15 : 1005 - 1023
[24] The Influence of Gender and Age on Neonatal Rat Hypothalamic 5-HT1A and 5-HT2A Receptors
P.-F. Ferrari
S. Lowther
H. Tidbury
P. Greengrass
C. A. Wilson
R. W. Horton
Cellular and Molecular Neurobiology, 1999, 19 : 775 - 784
[25] Serotonin 5-HT1A, 5-HT2A, and 5-HT7 Receptors in the Brain of the BTBR Mouse the Model of Autism
Rodnyy, A. Ya
Kulikova, E. A.
Kondaurova, E. M.
Naumenko, V. S.
NEUROCHEMICAL JOURNAL, 2021, 15 (01) : 42 - 49
[26] BINDING MODES OF LONG-CHAIN ARYLPIPERAZINES TO 5-HT1A, 5-HT2A AND 5-HT7 RECEPTORS
Bielenica, Anna
Kossakowski, Jerzy
BIULETYN WYDZIALU FARMACEUTYCZNEGO WARSZAWSKIEGO UNIWERSYTETU MEDYCZNEGO, 2010, (02): : 13 - 21
[27] Serotonin 5-HT1A, 5-HT2A, and 5-HT7 Receptors in the Brain of the BTBR Mouse the Model of Autism
A. Ya. Rodnyy
E. A. Kulikova
E. M. Kondaurova
V. S. Naumenko
Neurochemical Journal, 2021, 15 : 42 - 49
[28] Role of 5-HT1B, 5-HT2A and 5-HT2C receptors in learning
Meneses, A
Hong, E
BEHAVIOURAL BRAIN RESEARCH, 1997, 87 (01) : 105 - 110
[29] Co-expression of 5-HT1A and 5-HT2A receptors in prefrontal pyramidal neurones: role in the control of 5-HT and DA systems
Artigas, F.
Bortolozzi, A.
Scorza, M. C.
Amargos-Bosch, M.
Puig, M. V.
Serrtas, J.
Mengod, G.
Adell, A.
Celada, P.
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 134 - 134
[30] Ayahuasca-enhanced extinction of fear behaviour: Role of infralimbic cortex 5-HT2A and 5-HT1A receptors
Werle, Isabel
Nascimento, Laura M. M.
dos Santos, Aymee L. A.
Soares, Luciane A.
dos Santos, Rafael G.
Hallak, Jaime E. C.
Bertoglio, Leandro J.
BRITISH JOURNAL OF PHARMACOLOGY, 2024, 181 (11) : 1671 - 1689

← 1 2 3 4 5 →